DANAHER CORPORATION (NYSE:DHR) Files An 8-K Results of Operations and Financial Condition
ITEM 2.02RESULTS OF OPERATIONS AND FINANCIAL CONDITION
In advance of a publicly webcast presentation at the J.P. Morgan Healthcare Conference on January 8, 2019, on January 7, 2019, Danaher Corporation issued a press release regarding the Company’s anticipated financial performance for the fourth quarter of 2018, which is incorporated by reference herein.
This information shall not be deemed “filed” for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits:
DANAHER CORP /DE/ Exhibit
EX-99.1 2 exhibit991.htm EXHIBIT 99.1 Exhibit DANAHER CEO TO COMMENT ON FINANCIAL PERFORMANCEWashington,…
To view the full exhibit click here
About DANAHER CORPORATION (NYSE:DHR)
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services. Its Environmental segment products and services help protect the water supply, enhance the safety of personal data and improve business efficiencies. In the Life Sciences & Diagnostics segment, its diagnostics business offers analytical instruments, reagents, consumables, software and services. Its life sciences business offers research tools. Its Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. Its Industrial Technologies segment solutions help protect the world’s food supply, improve packaging design and quality, and verify pharmaceutical dosages.
